COVID-19 Survivorship Registry

This observational study is looking at the short and long-term effects of COVID-19 infection on your heart and lungs, as well as your mental health and quality of life. Researchers will use questionnaires to understand how COVID-19 impacts depression, anxiety, and overall well-being. They will also measure inflammatory markers (substances in your blood that indicate inflammation) for up to 12 months. You may be able to join if you are 18 or older, have tested positive for SARS-CoV-2 (the virus that causes COVID-19), and were either discharged from the ICU, discharged from the hospital, or were not hospitalized at all. The study aims to enroll 1500 participants.

Study design: This is an observational study, meaning researchers will collect information without giving you a specific treatment. It aims to enroll 1500 participants.
What's involved: You would complete various questionnaires to assess your mental health and quality of life. Your inflammatory markers will be measured for up to 12 months.
Compensation: Not stated in the trial record.
Follow-up: Your inflammatory markers will be measured for up to 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

COVID-19 Survivorship Registry

Recruiting

Not specifiedAges 18+Observational

NYU Langone Health

~1,500 participants

Updated 2025-10-30 on ClinicalTrials.gov

What's tested:Questionnaires

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Level of Inflammatory Markers

Measured over Up to 12 months

Conditions

Covid19

Where it's being run

1 sites across 1 states

New York1

Study leadership

Rany Condos, MD · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Who to contact

Ashley Witzl

[email protected]

212-263-1208

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

have tested positive for SARS-CoV-2 and discharged from the ICU or,

have tested positive for SARS-CoV-2 and have been discharged from hospital or,

have tested positive for SARS-CoV-2 but was NOT hospitalized

ages 18 and over, and

competent and willing to sign informed consent and comply to all aspects of the protocol

No clinical history of COVID-19,

No active clinical symptoms indicative of possible COVID-19,

Ages 18 and over,

competent and willing to sign informed consent and comply to all aspects of the protocol

Exclusion

Participants who are pregnant or currently trying to get pregnant

Participants unable to comply with any portion of the protocol (i.e. removing metals prior to entering the MRI scan room) or who have contraindications to MRI scanning (i.e., non-MRI-conditional pacemakers/defibrillators, pregnancy, ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants)

Persistent symptoms related to COVID-19 (in which case the patient may be re-screened later) As is done for all patients undergoing clinical MRI in our department, each patient will be screened for contraindications to MRI with a routine questionnaire prior to scanning.

Pace maker

Poorly controlled diabetes

Poorly controlled Restrictive lung disease

Heart failure

Parkinson's Disease

Hypertension

Any diagnosis or history of autonomic neuropathy

What this trial measures

Level of Inflammatory MarkersUp to 12 months
Inflammatory markers include D-dimer, ferritin, and CRP measurements

Trialytics